The resources available for the public provision of health care are not unlimited. Cost-effectiveness evidence on new healthcare interventions can help us prioritise in order to use scarce resources wisely, but to interpret cost-effectiveness evidence, it may appear as if we must make trade-offs between life and money.
This is not so. If we are able to quantify the health improvements that resources would or could have generated in alternative use, a decision about providing or denying treatment can instead be framed as a trade-off between health gained and health forgone.
In my research, I seek to provide a more robust basis for this way of reporting and interpreting cost-effectiveness evidence.
- B.Sc. in Political Sciences, 2013
- M.Sc. in Economics, 2015
- Ph.D. in Medical Sciences, 2022
I teach econometrics at the Master Programme in Economics.